Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00246077 · ClinicalTrials.gov registry record
Quality of Life of Children With Sickle Cell Disease Who Are Getting Chronic Transfusions With a Lifeport
A clinical trial of Anemia, Sickle Cell, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 5
- Enrollment target
- 1
- Study location
NCT00246077: Completed study of Anemia, Sickle Cell, sponsored by Children's Mercy Hospital Kansas City.
NCT00246077 is a study of Anemia, Sickle Cell that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 5 participants, below the 118-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00246077, a study of Anemia, Sickle Cell, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to see what impact having a Lifeport device has on quality of life for children with sickle cell who are getting chronic transfusions, from the child's perspective.
Conditions Studied
Study Locations (1)
Missouri
- The Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2005-10 |
| Est. Completion | 2005-12 |
What the finished NCT00246077 record still lists
NCT00246077 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 118-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Anemia, Sickle Cell appearing as the primary indexed condition, and to 0 interventions.
NCT00246077 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT00246077 about?
NCT00246077 is a clinical study titled "Quality of Life of Children With Sickle Cell Disease Who Are Getting Chronic Transfusions With a Lifeport". This study is being done to see what impact having a Lifeport device has on quality of life for children with sickle cell who are getting chronic transfusions, from the child's perspective.
What is the current status of trial NCT00246077?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2005-10. Estimated completion is 2005-12.
What conditions does trial NCT00246077 study?
This clinical trial studies the following conditions: Anemia, Sickle Cell.
Who is sponsoring clinical trial NCT00246077?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00246077 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia, Sickle Cell
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00246077's enrollment target sits among peer trials
5 17th of 17 higher than 1 of 17 other Anemia, Sickle Cell trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia, Sickle Cell trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
RECRUITING · Phase 2
-
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
RECRUITING · Phase 1
-
Metabolic and Hemodynamic Reserve in Pediatric SCA
RECRUITING · NA
-
A Blood Stem Cell Transplant for Sickle Cell Disease
ACTIVE NOT RECRUITING · Phase 1
-
Therapeutic Response Evaluation and Adherence Trial (TREAT)
ACTIVE NOT RECRUITING · NA
-
Epidemiology of Silent and Overt Strokes in Sickle Cell Disease
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia